VR Logo

Unrated

UTI Healthcare Fund - Direct Plan


1 Lakh

Investment Grown to
₹ 1.91 Lakh

₹ 10000

Monthly SIP Grown to
₹ 6.17 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 20.63 0.82 -1.13 3.52 6.66 27.88 35.03 24.01 13.37 12.22 --
S&P BSE Healthcare TRI 21.85 0.69 -1.65 2.41 5.92 28.36 34.76 19.80 10.45 10.07 --
Equity: Sectoral-Pharma 21.03 0.71 -1.43 2.57 7.08 27.72 35.44 26.09 14.12 13.58 --
Rank within category 5 4 2 2 6 5 6 5 3 3 --
Number of funds in category 10 10 10 10 10 10 9 6 4 3 0

As on 21-Sep-2021

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
UTI Healthcare Fund - Direct Plan  | Invest Online
Unrated
Jan-13 35.03 24.01 13.37 1.28 897
Nippon India Pharma Fund - Direct Plan
Unrated
Jan-13 39.70 25.46 17.31 1.14 5,667
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan  | Invest Now
Unrated
Jul-18 33.56 27.07 -- 1.15 3,158
SBI Healthcare Opportunities Fund - Direct Plan  | Invest Online
Unrated
Jan-13 35.31 22.78 10.92 1.05 2,048
Mirae Asset Healthcare Fund - Direct Plan  | Invest Online
Unrated
Jul-18 39.96 31.68 -- 0.56 1,901

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 21.26 01-Apr-2020 - 09-Apr-2020 -11.14 05-Mar-2020 - 12-Mar-2020
Month 34.34 23-Mar-2020 - 22-Apr-2020 -19.45 20-Feb-2020 - 23-Mar-2020
Quarter 45.31 23-Mar-2020 - 22-Jun-2020 -15.00 07-Sep-2018 - 07-Dec-2018
Year 86.35 23-Mar-2020 - 23-Mar-2021 -18.18 06-Apr-2015 - 05-Apr-2016

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund 22.35 20.49 0.89 2.05 0.92 3.60
S&P BSE Healthcare TRI 20.04 21.96 0.73 1.60 -- --
Equity: Sectoral-Pharma 25.01 19.99 1.05 2.36 0.89 6.71
Rank within category 6 5 6 5 4 6
Number of funds in category 6 6 6 6 6 6

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 31-Aug-2021

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 29
Top 10 Stocks (%) 58.53
Top 5 Stocks (%) 36.97
Top 3 Sectors (%) 97.31
Portfolio P/B Ratio 4.78
Portfolio P/E Ratio 29.81

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 35,476 58,801
Giant (%) 8.40 15.06
Large (%) 37.47 45.41
Mid (%) 37.94 32.94
Small (%) 16.20 8.56
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Dr. Reddy's Lab Healthcare 46.36 11.67 3.48 9.13
down Sun Pharmaceutical Industries Healthcare 30.79 15.05 6.63 8.17
equal Cipla Healthcare 30.61 10.43 3.52 7.86
down Divi's Laboratories Healthcare 66.84 9.85 4.81 5.94
up Aurobindo Pharma Healthcare 8.04 9.55 2.36 5.87
down Fortis Healthcare Healthcare -- 5.21 0.00 5.21
down Ajanta Pharma Healthcare 27.71 5.58 2.44 4.26
down Eris Lifesciences Healthcare 27.34 5.68 0.00 4.12
down Apollo Hospitals Healthcare 469.17 4.09 0.00 4.09
up Ipca Laboratories Healthcare 30.77 7.79 2.45 3.88
down JB Chemicals & Pharma Healthcare 30.05 3.97 0.00 3.32
down Narayana Hrudayalaya Healthcare 60.12 4.36 0.00 3.31
down FDC Healthcare 19.35 4.36 1.27 3.04
down Alkem Laboratories Healthcare 28.47 4.75 0.00 2.93
down Cadila Healthcare Healthcare 25.35 9.87 2.89 2.89
down Krishna Institute Of Medical Sciences Healthcare 48.58 2.80 0.00 2.80
equal Abbott India Healthcare 64.55 2.79 0.00 2.18
down Gland Pharma Healthcare 63.92 3.31 0.00 2.14
down Advanced Enzyme Technologies FMCG 29.16 3.03 0.00 2.04
up Lupin Healthcare 25.81 9.90 1.99 1.99
down Metropolis Healthcare Healthcare 60.40 1.94 0.00 1.77
equal Alembic Pharmaceuticals Healthcare 15.32 2.54 0.00 1.73
equal Poly Medicure Healthcare 61.77 1.72 0.00 1.53
down Torrent Pharmaceuticals Healthcare 41.39 6.87 0.99 1.48
equal Suven Pharmaceuticals Healthcare 37.82 1.36 0.00 1.33

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Aug-2021

Fund Manager

— V Srivatsa since 02-Mar-2017

Education: Mr. Srivatsa is a B.Com (H), Chartered Accountant, CWA. and PGDM from IIM Indore.

Experience: Prior to joining UTI in 2002 he has worked with Ford, Rhodes Parks & Co., Chartered Accountants and Madras Cements Ltd.

Funds Managed:


0.82%

Change from previous, NAV as on 21-Sep-2021

Growth: ₹ 184.5215

IDCW: ₹ 142.6228


Investment Strategy

The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 500
Minimum No of Cheques 6
Minimum Withdrawal (₹) --
Minimum Balance (₹) 5,000
Lock-in Period Not Applicable
Exit Load 1% for redemption within 30 days

Basic Details

Fund House: UTI Mutual Fund
Launch Date: 01-Jan-2013
Return Since Launch: 16.77%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 897 Cr (As on 31-Aug-2021)
Expense: 1.28% (As on 31-Aug-2021)
Risk Grade: --
Return Grade: --
Turnover: 50.00%

Contact Information

AMC: UTI Asset Management Company Ltd

Address: UTI Tower, 'GN' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051

Phone: 022- 66786666 / 66786354 / 1800-22-1230

Fax: 022-26523031

Email: [email protected]

Website: http://www.utimf.com

Registrar & Transfer Agent: KFin Technologies Pvt Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

Viewpoint

The Case for ESG Investing

DateThursday, 30-Sep-2021
Time04:00 PM - 04:30 PM